Procter & Gamble Health Ltd.

₹ 5,275.60

70.00 (1.31%)

Daily Range

Today's Low

₹ 5,221.00

Today's High

₹ 5,315.00

52 Weeks Range

52 Weeks Low

₹ 3,870.10

52 Weeks High

₹ 5,249.00

Momentum of the Stock

Bearish

Circuit Limit

Lower

₹ 4,220.50

Upper

₹ 6,330.70

Financials Strength Score

9 Strong19

Piotroski Score

Company Profile

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Companies under the same Group

No Data Found

Key Metrics

Standalone

Consolidated

No of shares Outstanding

1.7 Cr.

EPS-TTM

₹142.52

Face Value

₹10.00

Book Value

₹367.76

Net Asset Value

₹319.10

ROE

31.58%

ROA

9.49%

ROCE

42.52%

Dividend Yield

4.91%

Total Debt

₹ 0.0 Cr.

Sales Growth

-6.37%

PAT Growth

-12.42%

Financials

StandaloneConsolidated

Balance Sheet

(All Values are in INR Cr.)

Particulars	FY 2022	FY 2021	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998
Total Current Assets	989.5	1,038.9	1,264.8	1,889.2	879.3	750.2	946.0	623.2	602.3	556.5	784.1	375.3	504.1	432.8	375.5	363.8	330.2	265.5	207.6	160.2	135.6	109.9	102.7	96.5
Total Non-Current Assets	954.0	939.0	847.3	693.5	636.7	613.1	579.5	581.0	170.5	460.0	120.3	51.2	64.0	127.7	114.0	113.8	52.7	55.2	61.6	72.0	76.0	81.1	65.3	64.5
Total Assets	1,943.5	1,977.8	2,112.1	2,582.6	1,516.0	1,363.3	1,525.5	1,204.2	772.8	1,016.5	904.4	426.5	568.2	560.5	489.5	477.6	382.9	320.6	269.2	245.9	215.0	191.0	168.1	161.0
Total Current Liabilities	611.7	550.7	538.6	547.7	352.2	300.5	538.9	259.8	236.5	195.1	481.2	83.6	98.8	106.8	61.8	80.0	82.2	70.1	71.7	60.5	55.9	54.6	50.6	47.2
Total Non-Current Liabilities	715.3	723.4	667.2	494.8	430.5	398.9	395.0	390.1	13.3	337.7	13.1	-3.5	2.1	2.4	4.8	4.6	2.5	2.3	1.3	9.8	8.6	4.6	12.3	18.9
Shareholder's Funds	616.5	703.7	906.3	1,540.1	733.3	663.8	591.6	554.3	523.0	483.7	410.1	346.4	467.3	451.4	422.9	393.0	298.1	248.2	196.3	175.6	150.5	131.8	105.2	95.0
Total Liabilities	1,943.5	1,977.8	2,112.1	2,582.6	1,516.0	1,363.3	1,525.5	1,204.2	772.8	1,016.5	904.4	426.5	568.2	560.5	489.5	477.6	382.9	320.6	269.2	245.9	215.0	191.0	168.1	161.0

Financial Statement Analysis

Price to BV
The Industry Price to BV stands at 16.12, vs the Price to BV of 16.12, which results in a Positive aspect.
Debt to Equity Ratio
The Industry Debt to Equity Ratio stands at 0.00, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
Current Ratio
The Industry Current Ratio stands at 1.72, vs the Current Ratio of 1.72, which results in a Positive aspect.
Quick Ratio
The Industry Quick Ratio stands at 1.53, vs the Quick Ratio of 1.53, which results in a Positive aspect.

Profit and Loss Statement

(All Values are in INR Cr.)

Particulars	FY 2022	FY 2021	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000
Total Income	1,114.4	1,008.7	1,355.9	849.0	698.1	992.6	939.5	867.5	797.8	687.3	589.6	509.1	473.1	389.5	314.8	329.5	396.5	376.6	364.2	346.7	337.1	311.4
Total Expenditure	846.7	762.7	1,041.5	704.9	627.5	877.0	856.1	808.6	720.9	581.8	517.1	435.3	412.3	339.7	248.4	250.1	290.0	273.1	271.0	281.4	272.7	255.8
Operating Profit(Excl OI)	280.9	264.1	384.3	172.5	101.0	140.0	106.8	79.2	98.3	125.7	103.7	117.2	104.0	97.5	106.5	110.7	125.0	117.4	104.0	74.5	73.4	62.0
Add: Other Income	13.2	18.1	70.0	28.4	30.4	24.4	23.3	20.3	21.5	20.2	31.2	43.4	43.2	47.7	40.0	31.3	18.6	13.9	10.9	9.2	9.0	6.4
Operating Profit	280.9	264.1	384.3	172.5	101.0	140.0	106.8	79.2	98.3	125.7	103.7	117.2	104.0	97.5	106.5	110.7	125.0	117.4	104.0	74.5	73.4	62.0
Less: Interest	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.4	0.6	2.3
PBDT	280.5	263.3	384.3	172.5	101.0	140.0	106.8	79.2	98.3	125.7	103.5	117.1	104.0	97.5	106.5	110.6	125.0	117.2	103.2	74.1	72.8	59.7
Less: Depreciation Amortization	27.1	30.0	29.5	21.1	19.1	24.8	23.4	12.7	10.1	8.9	8.0	7.1	7.5	5.7	6.6	6.4	7.8	8.6	9.6	10.0	9.5	7.3
PBT & Exceptional Items	253.4	233.3	354.9	151.4	81.9	115.2	83.3	66.6	88.3	116.8	95.6	110.0	96.5	91.7	99.9	104.2	117.3	108.6	93.6	64.1	63.3	52.4
Less: Exceptional Income Expenses	0.0	0.0	0.0	6.6	17.0	0.0	0.0	0.0	0.0	0.0	0.0	-14.3	0.0	0.0	0.0	65.5	0.0	0.0	-34.5	-3.4	0.0	0.0
Profit Before Tax	253.4	233.3	354.9	158.0	98.9	115.2	83.3	66.6	88.3	116.8	95.6	95.7	96.5	91.7	99.9	169.7	117.3	108.6	59.1	60.7	63.3	52.4
Less: Taxation	60.9	56.5	100.8	56.2	37.9	36.0	29.8	23.3	32.4	38.4	31.9	32.5	31.0	28.7	31.0	36.4	38.5	37.6	19.5	20.7	18.6	13.9
Profit After Tax	192.5	176.8	254.1	101.7	61.0	79.1	53.6	43.2	55.9	78.4	63.7	63.2	65.5	63.0	68.8	133.4	78.8	71.0	39.6	40.0	44.7	38.5
Earnings Per Share	1.2	1.1	1.5	0.6	3.7	4.8	3.2	2.6	3.4	4.7	3.8	3.8	3.9	3.7	4.1	7.9	4.7	4.2	2.4	2.4	2.7	2.3

Financial Statement Analysis

PE Ratio
The Industry PE Ratio stands at 43.16, vs the PE Ratio of 43.16, which results in a Positive aspect.
Dividend Yield
The Industry Dividend Yield stands at 4.98, vs the Dividend Yield of 4.98, which results in a Positive aspect.
PAT Margin
The Industry PAT Margin stands at 17.28, vs the PAT Margin of 17.28, which results in a Positive aspect.
PAT Growth
The Industry PAT Growth stands at 19.19, vs the PAT Growth of 19.19, which results in a Positive aspect.

Cash Flow Statement

(All Values are in INR Cr.)

Particulars	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Profit Before Tax	273.3	314.2	253.4	233.3	354.9	1,137.6	152.2	115.2	83.3	66.6	88.3	116.8	95.6	95.7	96.5	91.7
Tax Paid	-85.2	-89.7	-63.9	-68.1	-101.6	-304.0	-59.5	-53.1	-31.8	-34.2	-39.8	-39.8	-30.5	-38.9	-32.0	-37.6
Adjustment	52.3	41.5	27.3	40.9	-12.2	-913.7	7.7	14.9	16.3	21.1	3.0	-7.8	-18.4	2.8	-18.7	-21.3
Changes In Working Capital	273.3	314.2	253.4	233.3	354.9	1,137.6	152.2	115.2	83.3	66.6	88.3	116.8	95.6	95.7	96.5	91.7
Cash Flow after changes in Working Capital	313.5	325.7	233.4	315.4	337.0	173.6	113.2	160.2	115.3	39.1	40.3	94.1	49.2	104.0	72.9	40.8
Cash Flow from Operating Activities	228.3	236.0	169.5	247.3	235.4	-130.4	53.7	107.0	83.5	5.0	0.5	54.3	18.8	66.0	41.7	3.9
Cash Flow from Investing Activities	-6.9	-21.5	-25.5	-32.3	164.6	1,269.7	-47.6	-75.0	-67.8	10.6	7.0	-81.8	-9.1	176.4	1.6	15.8
Cash Flow from Financing Activities	-418.1	-98.5	-288.6	-386.6	-883.4	-30.1	-22.0	-15.0	-11.9	-16.6	-4.8	0.0	0.0	-221.9	-45.2	-19.7
Net Cash Inflow / Outflow	-196.7	116.0	-144.7	-171.6	-483.4	1,109.2	-16.0	17.1	3.7	-1.1	2.7	-27.6	9.7	20.4	-1.9	0.0
Opening Cash & Cash Equivalents	435.4	319.4	464.1	635.7	1,119.1	9.9	26.3	9.2	5.5	6.6	3.9	31.5	21.8	1.3	3.2	3.2
Closing Cash & Cash Equivalent	238.7	435.4	319.4	464.1	635.7	1,119.1	10.3	26.3	9.2	5.5	6.6	3.9	31.5	21.8	1.3	3.2

Financial Statement Analysis

PCF RATIO
The Industry PCF RATIO stands at 36.92, vs the PCF RATIO of 36.92, which results in a Positive aspect.
PFCF Ratio
The Industry PFCF Ratio stands at 47.09, vs the PFCF Ratio of 47.09, which results in a Positive aspect.

Quarterly Reports

(All Values are in INR Cr.)

Particulars	Dec 2024	Sep 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020
Net Sales	3,097.7	3,134.1	3,099.7	3,049.3	3,011.8	3,209.2	3,099.7	2,975.5	2,958.9	2,678.2	2,779.0	2,728.0	2,853.9	2,191.5	2,402.2	2,639.7	2,011.6	2,281.1
Total Income	3,137.3	3,166.9	3,151.5	3,109.8	3,066.4	3,258.9	3,145.1	3,009.7	2,989.9	2,701.7	2,826.0	2,758.4	2,878.1	2,223.9	2,459.4	2,706.9	2,118.4	2,383.7
Total Expenditure	1,863.4	1,993.7	2,083.2	2,162.7	2,558.4	2,412.6	1,995.9	2,067.3	2,368.5	1,990.5	2,160.6	1,947.3	2,369.5	1,884.2	1,514.7	1,858.7	1,480.7	1,693.7
PBIDT (Excl OI)	1,234.3	1,140.4	1,016.5	886.6	453.4	796.6	1,103.8	908.2	590.4	687.7	618.4	780.7	484.4	307.3	887.5	781.0	530.9	587.4
Other Income	39.6	32.8	51.8	60.5	54.6	49.7	45.4	34.2	31.0	23.5	47.0	30.4	24.2	32.4	57.2	67.2	106.8	102.6
Operating Profit	1,273.9	1,173.2	1,068.3	947.1	508.0	846.3	1,149.2	942.4	621.4	711.2	665.4	811.1	508.6	339.7	944.7	848.2	637.7	690.0
Interest	1.5	1.5	1.9	1.8	1.7	2.1	2.3	1.6	0.2	1.4	1.2	1.4	1.7	2.0	1.9	2.4	0.0	0.0
Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PBDT	1,272.4	1,171.7	1,066.4	945.3	506.3	844.2	1,146.9	940.8	621.2	709.8	664.2	809.7	506.9	337.7	942.8	845.8	637.7	690.0
Depreciation	55.5	57.7	69.2	64.8	65.0	58.9	97.5	74.8	74.7	61.2	65.9	69.0	71.6	76.7	78.5	73.6	80.5	42.4
Profit Before Tax	1,216.9	1,114.0	997.2	880.5	441.3	785.3	1,049.4	866.0	546.5	648.6	598.3	740.7	435.3	261.0	864.3	772.2	557.3	647.6
Tax	307.9	290.7	276.5	224.8	143.1	193.4	281.4	229.4	134.6	137.0	149.9	187.0	96.4	103.3	185.5	179.6	68.7	183.0
Provisions and contingencies	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit After Tax	909.0	823.3	720.7	655.7	298.2	591.9	768.0	636.6	411.9	511.6	448.4	553.7	338.9	157.7	678.8	592.6	488.6	464.6
Net Profit	909.0	823.3	720.7	655.7	298.2	591.9	768.0	636.6	411.9	511.6	448.4	553.7	338.9	157.7	678.8	592.6	488.6	464.6
ADDITIONAL INFOS:
Equity Capital	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0	166.0
Reserves	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPS	54.8	49.6	43.4	39.5	18.0	35.7	46.3	38.3	24.8	30.8	27.0	33.4	20.4	9.5	40.9	35.7	29.4	28.0
Operating Profit Margin	41.1	37.4	34.5	31.1	16.9	26.4	37.1	31.7	21.0	26.6	23.9	29.7	17.8	15.5	39.3	32.1	31.7	30.2
Net Profit Margin	29.3	26.3	23.3	21.5	9.9	18.4	24.8	21.4	13.9	19.1	16.1	20.3	11.9	7.2	28.3	22.4	24.3	20.4

Financial Statement Analysis

Net Sales Growth
The Industry Net Sales Growth stands at 10.34, vs the Net Sales Growth of 10.34, which results in a Positive aspect.
Mcap Growth
The Industry Mcap Growth stands at 25.36, vs the Mcap Growth of 25.36, which results in a Positive aspect.

Technicals

Pivot Levels

Check Advanced Levels

Type	Classic	Woodie	Camarilla
R4	5,463.60	5,553.80	5,327.30
R3	5,414.07	5,416.60	5,301.45
R2	5,364.53	5,365.80	5,292.83
R1	5,320.07	5,322.60	5,284.22
Pivot	5,270.53	5,271.80	5,270.53
S1	5,226.07	5,228.60	5,266.98
S2	5,176.53	5,177.80	5,258.37
S3	5,132.07	5,134.60	5,249.75
S4	5,087.60	4,989.80	5,223.90

(All Values are in INR)

The Pivot level gives the user an indication about key support & resistance levels for a selected stock.

EMA & SMA Levels

5 Day

4,926.25

10 Day

4,851.23

20 Day

4,818.96

50 Day

5,041.14

100 Day

5,061.04

200 Day

5,092.71

Beta

1 Day

0.44

1 Week

0.43

1 Month

0.41 Indicators

Stoch RSI
100.00
Bearish
RSI
67.43
Neutral
ROC
-2.55
Bearish
UltimateOscillator
54.99
Neutral
Williams Indicator
-60.89
Neutral
CCI Indicator
-55.40
Neutral
MACD
732.57
Bullish
Stochastic Indicator
45.47
Neutral
ATR
125.02
High Volatility

Corporate Actions

Corporate Actions - Board Meet

Announcement Date	Dividend Amount	Dividend Percentage of FV	Dividend Type
21-02-2025	80.00	800	Interim
28-11-2024	60.00	600	Final
14-02-2024	50.00	500	Interim
14-02-2024	150.00	1500	Special
23-11-2023	50.00	500	Final
13-11-2023	50.00	500	Final
13-02-2023	45.00	450	Interim
15-11-2022	11.50	115	Final
12-05-2022	41.00	410	Interim
02-11-2021	40.00	400	Final
02-11-2021	90.00	900	Special

Date Of Conduct	Board Meeting Details
12-02-2025	Quarterly Results & Interim Dividend
12-02-2025	Quarterly Results
04-11-2024	Quarterly Results
02-05-2024	Quarterly Results
06-02-2024	Quarterly Results & Interim Dividend
03-11-2023	Quarterly Results
23-08-2023	Final Dividend & Audited Results
15-05-2023	Quarterly Results
08-02-2023	Quarterly Results & Interim Dividend
05-02-2023	Quarterly Results (Revised) & Interim Dividend
11-11-2022	Quarterly Results (Revised)
09-11-2022	Quarterly Results
29-08-2022	Final Dividend & Audited Results
05-05-2022	Interim Dividend & Quarterly Results
09-02-2022	Quarterly Results
09-11-2021	Quarterly Results
26-08-2021	Final Dividend & Audited Results
06-05-2021	Quarterly Results

Frequently Asked Questions

The share price of PGHL is 5275.6.

You can easily buy PGHL shares by opening a Demat and trading Account from Enrich money free of cost. You can trade using their Web Trading Platform or Mobile App.

The Market Capitalization of Procter&Gamble Healtshare as on today is8,781.90Cr.

The Trailing Twelve Months (TTM) PE Ratio of Procter&Gamble Healtis37.12

The Earnings per Share (EPS) of Procter&Gamble Healtis142.52

The 52 Week Low of 4,636.55, and 52 Week High is 5,850.00

The share price changes based on the Share Market's Demand & Supply. Usually, the Beta of the Stock (Positive or Negative) measures the volatility of the stock. Based on this, the Procter&Gamble Healt share is 0.44 times volatile to the Index trend.

Ex-Date	Ratio	Record Date

Procter & Gamble Health Ltd.

₹ 5,275.60

Daily Range

52 Weeks Range

Momentum of the Stock

Bearish

Circuit Limit

Financials Strength Score

Piotroski Score

Company Profile

Companies under the same Group

Key Metrics

Standalone

Consolidated

1.7 Cr.

₹142.52

₹10.00

₹367.76

₹319.10

31.58%

9.49%

42.52%

4.91%

₹ 0.0 Cr.

-6.37%

-12.42%

Financials

Balance Sheet

Financial Statement Analysis

Price to BV

Debt to Equity Ratio

Current Ratio

Quick Ratio

Profit and Loss Statement

Financial Statement Analysis

PE Ratio

Dividend Yield

PAT Margin

PAT Growth

Cash Flow Statement

Financial Statement Analysis

PCF RATIO

PFCF Ratio

Quarterly Reports

Financial Statement Analysis

Net Sales Growth

Mcap Growth

Technicals

Pivot Levels

Check Advanced Levels

The Pivot level gives the user an indication about key support & resistance levels for a selected stock.

EMA & SMA Levels

4,926.25

4,851.23

4,818.96

5,041.14

5,061.04

5,092.71

Beta

0.44

0.43

0.41

Indicators

Corporate Actions

Corporate Actions - Board Meet

Frequently Asked Questions

What is the share price of Procter&Gamble Healt today?

How do I buy Procter&Gamble Healt shares online?

What is the Market Cap of Procter&Gamble Healt today?

What is the Price to Earnings Ratio (PE Ratio) of Procter&Gamble Healt?

What is the Earnings per Share (EPS) of Procter&Gamble Healt?

What is the 52 Week High and 52 Week Low of Procter&Gamble Healt?

How Volatile is Procter&Gamble Healt share today?